Bonek, R.; Guenter, W.; Jałowiński, R.; Karbicka, A.; Litwin, A.; Maciejowski, M.; Zajdel, R.; Zajdel, K.; Petit, V.; Rejdak, K.
JC Virus Seroprevalence and JCVAb Index in Polish Multiple Sclerosis Patients Treated with Immunomodulating or Immunosuppressive Therapies. J. Clin. Med. 2021, 10, 1998.
https://doi.org/10.3390/jcm10091998
AMA Style
Bonek R, Guenter W, Jałowiński R, Karbicka A, Litwin A, Maciejowski M, Zajdel R, Zajdel K, Petit V, Rejdak K.
JC Virus Seroprevalence and JCVAb Index in Polish Multiple Sclerosis Patients Treated with Immunomodulating or Immunosuppressive Therapies. Journal of Clinical Medicine. 2021; 10(9):1998.
https://doi.org/10.3390/jcm10091998
Chicago/Turabian Style
Bonek, Robert, Wojciech Guenter, Robert Jałowiński, Anna Karbicka, Anna Litwin, Maciej Maciejowski, Radosław Zajdel, Karolina Zajdel, Veronique Petit, and Konrad Rejdak.
2021. "JC Virus Seroprevalence and JCVAb Index in Polish Multiple Sclerosis Patients Treated with Immunomodulating or Immunosuppressive Therapies" Journal of Clinical Medicine 10, no. 9: 1998.
https://doi.org/10.3390/jcm10091998
APA Style
Bonek, R., Guenter, W., Jałowiński, R., Karbicka, A., Litwin, A., Maciejowski, M., Zajdel, R., Zajdel, K., Petit, V., & Rejdak, K.
(2021). JC Virus Seroprevalence and JCVAb Index in Polish Multiple Sclerosis Patients Treated with Immunomodulating or Immunosuppressive Therapies. Journal of Clinical Medicine, 10(9), 1998.
https://doi.org/10.3390/jcm10091998